LIPO - LIPELLA PHARMACEUTICALS INC.
IEX Last Trade
3.24
-0.080 -2.469%
Share volume: 0
Last Updated: Fri 27 Dec 2024 08:30:39 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$3.32
-0.08
-2.41%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
7.09%
1 Month
12.54%
3 Months
576.72%
6 Months
637.78%
1 Year
242.27%
2 Year
-9.29%
Key data
Stock price
$3.24
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.32 - $3.56
52 WEEK CHANGE
$225.49
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Jon Kaufman
Region: US
Website: lipella.com
Employees: 4
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: lipella.com
Employees: 4
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
We are a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Our principal executive offices are located at 7800 Susquehanna Street, Suite 505, Pittsburgh, PA.
Recent news